FGP
LMAT icon

Freestone Grove Partners’s LeMaitre Vascular LMAT Stock Holding History

Freestone Grove Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,166
Closed -$292K – 703
2024
Q4 		$292K Buy
+3,166
New +$304K ﹤0.01% 472

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Freestone Grove Partners's LMAT Position: Q1 2025 in Review

Freestone Grove Partners sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 3,166 shares — an estimated $292K sold.

Freestone Grove Partners first reported a position in LMAT in Q4 2024 and held it in 1 quarter. The position peaked at $292K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Freestone Grove Partners reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 3,166 LeMaitre Vascular shares in Q1 2025, an estimated $292K.
  • Freestone Grove Partners first reported a position in LeMaitre Vascular in Q4 2024 and held it in 1 quarter.
  • Freestone Grove Partners's LeMaitre Vascular position peaked at $292K in Q4 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Freestone Grove Partners's 13F filing for Q1 2025, filed 15 May 2025.